Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The conclusion is to thoroughly test for causes of cat hair loss and treat accordingly, considering medication only after serious conditions are ruled out.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

More research is needed to understand how testosterone is maintained in adult males.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The document explains how male reproductive hormones work and affect the body.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Women with PCOS often have liver disease, so liver health checks are important for them.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Moderately high prolactin levels do not cause hair loss in women.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.